From solid tumors to metastatic carcinomas and leukemia: cancer is among the most common causes of death and has many faces. Keep reading for latest developments in early detection, staging, therapy and research.
Tumour-infiltrating lymphocytes are key players in cancer immunotherapy. New research explores the role of location in the tumour microenvironment – knowledge that could help improve treatments.
Photothermal therapy to selectively destroy cancer cells shows promise as a much less invasive treatment option than surgery or radiation. Now, researchers cleared two major hurdles for the method.
A swallowable "nanocage" may offer a new strategy for treating gastric cancer more precisely while reducing damage to healthy tissue, according to findings from a new preclinical study.
Ultra-fast delivery, fewer side-effects: Results from the FAST-02 trial show that proton Flash therapy can be safely delivered to cancer patients with metastases in proximity to vital organs.
Tiny algae-based robots guided by magnets could improve bladder cancer treatment by boosting delivery of chemotherapy drugs into tumours, results from a new study suggest.
Radiopharmaceutical therapy has already transformed care for neuroendocrine tumors and prostate cancer, but other tumor types still lack targeted treatment options. A new approach could change this.
A new survey highlights major gaps in cardio-oncology training, despite its increasing clinical importance for prevention and early management of cardiovascular complications in patients with cancer.
Measuring radiodensity of visceral fat and muscle from CT scans, researchers have identified a new biomarker that may help determine the prognosis for patients with gastric cancer.
A Taiwanese research team found that BET inhibitors can restore exhausted T cells by reprogramming their metabolism – a potential new strategy for cancer immunotherapy.
AI is transforming the way cancer is diagnosed and treated. Dr Yuri Tolkach shared his group's advances in developing AI-based tools for oncological pathology at the DPAI Europe congress.
Prof. Johanna Joyce has begun her two-year term as President of the European Association for Cancer Research (EACR), a global community of scientists and clinicians dedicated to advancing the scientific understanding of cancer and its application to improve patient care.
Blood tests show promise for detecting and monitoring cancer. A new method makes it possible to analyse samples containing as little as 5% cancer DNA, compared with the 15–20% required today.
Substantial and sustained weight-loss after bariatric surgery has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues as to why.
Pancreas lesions are of diagnostic concern, as they may evolve into pancreatic cancer – but many never do. New research findings help explain how the transformation into a malignant state works.
United Imaging debuts its CE-marked uRT-linac 506c at ESTRO 2026 – a CT-linac system with native AI architecture for adaptive radiotherapy workflows.
Researchers have reported results from a first-in-human trial evaluating a novel cell-based platform for localized delivery of interleukin-2 (IL-2) in patients with advanced ovarian cancer.
A new ultrasonic needle for tumour diagnostics could be used to diagnose salivary gland tumours with far greater precision, a new study finds. The device also shows potential for other cancers.
New research reveals that testosterone slows glioblastoma growth—the opposite of the androgen’s effect on tumors outside the brain.
A CRISPR-based tool called Cas12a2 can selectively eliminate cancer and virus-infected cells based on their RNA signature – with high precision and no off-target effects.
